Prevalence and Predictive Factors of Difficult Biliary Cannulation
Launched by UNIVERSITY OF LA LAGUNA · Sep 7, 2024
Trial Information
Current as of July 05, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a specific issue called "difficult biliary cannulation," which can happen during a procedure known as endoscopic retrograde cholangiopancreatography (ERCP). This procedure is used to examine the bile ducts and can sometimes be challenging. The study aims to find out how often this problem occurs and what factors might make it more likely to happen. Researchers will be looking at patients who need an ERCP across multiple centers to gather their experiences and data.
To be eligible for this study, participants must be over 18 years old and provide their consent to join. They should be patients who have been advised to undergo an ERCP. However, people with certain health conditions, like those with high blood clotting risks or specific previous surgeries, will not be included. Participants can expect to contribute to important research that could help improve ERCP procedures in the future, and the study will also keep track of the resources used during the process.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>18 years
- • Signed informed consent
- • Patients indicated for ERCP
- Exclusion Criteria:
- • INR \> 1.5
- • Platelets \< 50,000/mm³
- • Patients with a prior endoscopic sphincterotomy
- • Papilla of Vater not accessible via duodenoscope (gastric or duodenal stenosis due to neoplasm) or gastric surgery (Billroth II, Roux-en-Y)
- • Known pancreas divisum
- • Indication due to pancreatic duct pathology
About University Of La Laguna
The University of La Laguna is a distinguished academic institution located in Spain, recognized for its commitment to advancing research and education in the health sciences. As a clinical trial sponsor, the university leverages its extensive expertise and innovative approaches to facilitate rigorous scientific investigations aimed at improving patient outcomes. The institution fosters collaboration among interdisciplinary teams of researchers, clinicians, and students, ensuring that its clinical trials adhere to the highest ethical standards and regulatory requirements. By promoting cutting-edge research initiatives, the University of La Laguna contributes significantly to the global body of knowledge in healthcare and medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Antonio Z Gimeno García, MD, PhD
Principal Investigator
University Hospital of the Canary Islands
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported